Women with polycystic ovary syndrome wedge resected in 1956 to 1965: a long-term follow-up focusing on natural history and circulating hormones - PubMed (original) (raw)
Clinical Trial
Women with polycystic ovary syndrome wedge resected in 1956 to 1965: a long-term follow-up focusing on natural history and circulating hormones
E Dahlgren et al. Fertil Steril. 1992 Mar.
Free article
Abstract
Objective: To determine if the hormonal imbalance in women with polycystic ovary syndrome (PCOS) continues into and after menopause and to analyze factors constituting an increased risk for developing metabolic disorders.
Design: The study was a transectional retrospective cohort follow-up of patients with PCOS.
Setting: The women with PCOS were recruited from hospital clinics, and referents were randomized from a population study of women.
Participants: Thirty-three women ages 40 to 59 years with ovarian histopathology typical of PCOS at wedge resection 22 to 31 years previously; 132 age-matched referents were analyzed.
Main outcome measures: Clinical data were collected via a questionnaire supplemented with an interview in connection to a clinical examination that also included fasting venous sampling.
Results: Infertility, hirsutism, and oligomenorrhea were more common among the subjects with PCOS, but there was a considerable spontaneous restitution of cyclic regularity with time. Women with PCOS were more often hysterectomized and entered menopause later compared with referents. The hormone data show a typical profile for PCOS. Compared with referents women with PCOS showed marked increase in prevalence of central obesity, higher basal serum insulin concentrations, and a higher prevalence of diabetes mellitus and hypertension.
Conclusion: Perimenopausal women with PCOS have an increased morbidity in hypertension and diabetes mellitus that adds to the classic symptoms, such as anovulation, hirsutism, and infertility.
Republished in
- Reprint of: Women with polycystic ovary syndrome wedge resected in 1956 to 1965: a long-term follow-up focusing on natural history and circulating hormones.
Dahlgren E, Johansson S, Lindstedt G, Knutsson F, Oden A, Janson PO, Mattson LA, Crona N, Lundberg PA. Dahlgren E, et al. Fertil Steril. 2019 Oct;112(4 Suppl1):e162-e170. doi: 10.1016/j.fertnstert.2019.08.084. Fertil Steril. 2019. PMID: 31623727 No abstract available.
Similar articles
- Reproductive hormone levels and anthropometry in postmenopausal women with polycystic ovary syndrome (PCOS): a 21-year follow-up study of women diagnosed with PCOS around 50 years ago and their age-matched controls.
Schmidt J, Brännström M, Landin-Wilhelmsen K, Dahlgren E. Schmidt J, et al. J Clin Endocrinol Metab. 2011 Jul;96(7):2178-85. doi: 10.1210/jc.2010-2959. Epub 2011 Apr 20. J Clin Endocrinol Metab. 2011. PMID: 21508129 - Androgen excess contributes to altered growth hormone/insulin-like growth factor-1 axis in nonobese women with polycystic ovary syndrome.
Wu X, Sallinen K, Zhou S, Su Y, Pöllänen P, Erkkola R. Wu X, et al. Fertil Steril. 2000 Apr;73(4):730-4. doi: 10.1016/s0015-0282(99)00634-2. Fertil Steril. 2000. PMID: 10731533 Clinical Trial. - A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile.
Diamanti-Kandarakis E, Kouli CR, Bergiele AT, Filandra FA, Tsianateli TC, Spina GG, Zapanti ED, Bartzis MI. Diamanti-Kandarakis E, et al. J Clin Endocrinol Metab. 1999 Nov;84(11):4006-11. doi: 10.1210/jcem.84.11.6148. J Clin Endocrinol Metab. 1999. PMID: 10566641 - The polycystic ovary syndrome. 1. Pathogenesis.
White MC, Turner EI. White MC, et al. Br J Hosp Med. 1994 Feb 16-Mar 1;51(4):167-74. Br J Hosp Med. 1994. PMID: 8012678 Review. - Hormonal changes in PCOS.
Yang J, Chen C. Yang J, et al. J Endocrinol. 2024 Feb 15;261(1):e230342. doi: 10.1530/JOE-23-0342. Print 2024 Apr 1. J Endocrinol. 2024. PMID: 38285626 Review.
Cited by
- Experimentally Induced Hyperinsulinemia Fails to Induce Polycystic Ovary Syndrome-like Traits in Female Rhesus Macaques.
Zhou R, Bruns CM, Bird IM, Kemnitz JW, Dumesic DA, Abbott DH. Zhou R, et al. Int J Mol Sci. 2022 Feb 27;23(5):2635. doi: 10.3390/ijms23052635. Int J Mol Sci. 2022. PMID: 35269778 Free PMC article. - Glucose intolerance states in women with the polycystic ovary syndrome.
Pasquali R, Gambineri A. Pasquali R, et al. J Endocrinol Invest. 2013 Sep;36(8):648-53. doi: 10.1007/BF03346757. J Endocrinol Invest. 2013. PMID: 24105073 Review. - How actual is the dietary treatment in overweighting patients with polycystic ovary syndrome?
Cortet-Rudelli C, Dewailly D. Cortet-Rudelli C, et al. J Endocrinol Invest. 1998 Oct;21(9):636-40. doi: 10.1007/BF03350791. J Endocrinol Invest. 1998. PMID: 9856420 Review. No abstract available. - Evidence for statin therapy in polycystic ovary syndrome.
Sathyapalan T, Atkin SL. Sathyapalan T, et al. Ther Adv Endocrinol Metab. 2010 Feb;1(1):15-22. doi: 10.1177/2042018810367984. Ther Adv Endocrinol Metab. 2010. PMID: 23148145 Free PMC article. - Complications and challenges associated with polycystic ovary syndrome: current perspectives.
Palomba S, Santagni S, Falbo A, La Sala GB. Palomba S, et al. Int J Womens Health. 2015 Jul 31;7:745-63. doi: 10.2147/IJWH.S70314. eCollection 2015. Int J Womens Health. 2015. PMID: 26261426 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical